Publicacións nas que colabora con JOSÉ CARLOS PLAZA HERNÁNDEZ (3)

2015

  1. SPARC expression did not predict efficacy of nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer in an exploratory analysis of the phase III MPACT trial

    Clinical Cancer Research, Vol. 21, Núm. 21, pp. 4811-4818

2014

  1. Reply: Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

    British Journal of Cancer

2013

  1. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

    British Journal of Cancer, Vol. 109, Núm. 4, pp. 926-933